Maravai Lifesciences Holdings Inc Earnings

The next earnings date for Maravai Lifesciences Holdings Inc is November 5, 2025.

They are scheduled to announce earnings after the market closes that day.

Analyst Estimates of Maravai Lifesciences Holdings Inc Earnings

Report DateEstimated Earnings Per Share
11/05/2025$-0.07

What is an Earnings Date

An earnings date is typically considered to be the date that a company publicly announces its earnings. Many companies in the US stock market do earnings announcements once per quarter.

Earnings announcements are typically accompanied by commentary from the company that explains the earnings performance and speaks to future earnings prospects.

Earnings announcements can cause a company’s stock price to change abruptly, so earnings dates are closely monitored by some investors.

Maravai Lifesciences Holdings Inc Earnings: Historical

Report DateBefore/After MarketEarnings Per ShareSurprise %
08/12/2025---$-0.08-9.89%
05/23/2025After Market$-0.020.00%
02/20/2025After Market------
11/07/2024After Market$-0.02-100.00%
08/07/2024After Market$-0.06-6,875.00%
05/08/2024After Market$-0.0233.33%
02/22/2024After Market$0.01200.00%
11/07/2023After Market$-0.01-200.00%
08/07/2023After Market$-0.05-600.00%
05/08/2023After Market$0.03-25.00%
02/22/2023After Market$0.352.94%
11/02/2022After Market$0.3712.12%
08/04/2022After Market$0.5420.00%
05/05/2022After Market$0.5422.73%
02/23/2022After Market$0.4518.42%
11/10/2021After Market$0.4425.71%
08/10/2021After Market$0.4437.50%
05/10/2021After Market$0.2623.81%
03/02/2021After Market$0.1318.18%
11/23/2020After Market$-0.02---

More About Maravai Lifesciences Holdings Inc

Country
USA
Full Time Employees
570

Maravai LifeSciences Holdings, Inc., a life sciences company, provides products that enable the development of drug therapies, vaccines, drug therapies, cell and gene therapies, and diagnostics North America, Europe, the Middle East, Africa, the Asia Pacific, and Latin and Central America. It operates in two segments, Nucleic Acid Production and Biologics Safety Testing. The Nucleic Acid Production segment manufactures and sells products for use in the fields of gene therapy, vaccines, nucleoside chemistry, and oligonucleotide therapy, as well as molecular diagnostics, including reagents used in the chemical synthesis, modification, labelling, and purification of deoxyribonucleic acid (DNA) and ribonucleic acid (RNA). This segment also offers messenger RNA, oligonucleotides, CleanCap capping technology-based oligonucleotide building blocks, and custom enzyme development and manufacturing; and research products for labeling and detecting proteins in cells and tissue samples. The Biologics Safety Testing segment sells analytical products for use in biologic manufacturing process development, including custom product-specific development antibody and assay development services. This segment also provides HCP ELISA kits, other bioprocess impurity and contaminant ELISA kits, ancillary reagents, viral clearance prediction kits, and custom services. The company's products address the key phases of biopharmaceutical development and include nucleic acids for diagnostic and therapeutic applications, and antibody-based products to detect impurities during the production of biopharmaceutical products. It serves biopharmaceutical companies, and other biopharmaceutical and life sciences research companies; and academic research institutions and in vitro diagnostics companies. Maravai LifeSciences Holdings, Inc. was founded in 2014 and is headquartered in San Diego, California.

Maravai Lifesciences Holdings Inc Earnings” Can Refer to the Maravai Lifesciences Holdings Inc Earnings Date

Some people say “Maravai Lifesciences Holdings Inc earnings” as a shortform way to refer to the earnings date.

For example, someone might say, “I plan to hold my Maravai Lifesciences Holdings Inc position through earnings.” That typically means the person is going to hold their position through the upcoming earnings date.

Owning Maravai Lifesciences Holdings Inc Stock on the Earnings Date

If you own Maravai Lifesciences Holdings Inc stock (MRVI) on the earnings date, then you will be exposed to the potential price volatility that often accompanies earnings announcements.

A company’s earnings typically have a big impact on its stock price, which explains why the stock price for Maravai Lifesciences Holdings Inc might exhibit major fluctuations on the day of the earnings announcement. The price fluctuations can go in either direction (up or down), representing a larger potential investment risk and reward than many other days of the year.

There is often a big audience of investors involved with trading Maravai Lifesciences Holdings Inc shares of stock on its earnings day. This means there is typically more trading volume, liquidity, and price volatility on the day earnings are announced.

These features are attractive to some types of active traders who are looking for stocks that exhibit large price movements and substantial volume.

Learning More Maravai Lifesciences Holdings Inc Earnings

You can contact us any time if you would like to ask questions about Maravai Lifesciences Holdings Inc earnings or anything else related to the stock market.

This site uses cookies to provide you with an optimal user experience. By using StockMarketGuides.com, you accept our use of cookies.